P
Philippe Wolf
Researcher at University of Strasbourg
Publications - 103
Citations - 3911
Philippe Wolf is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 32, co-authored 103 publications receiving 3613 citations. Previous affiliations of Philippe Wolf include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K. Geissler,Andreas A. Schnitzbauer,Andreas A. Schnitzbauer,Carl Zülke,P. Lamby,Andrea Proneth,Christophe Duvoux,Patrizia Burra,Karl-Walter Jauch,Markus Rentsch,Tom M. Ganten,Jan Schmidt,Utz Settmacher,Michael Heise,Michael Heise,Giorgio Rossi,Umberto Cillo,Norman M. Kneteman,René Adam,Bart van Hoek,Philippe Bachellier,Philippe Wolf,Lionel Rostaing,Wolf O. Bechstein,Magnus Rizell,James J. Powell,Ernest Hidalgo,J. Gugenheim,Heiner Wolters,Jens Brockmann,André Roy,Ingrid Mutzbauer,Angela Schlitt,Susanne Beckebaum,Christian Graeb,Silvio Nadalin,Umberto Valente,Victor Sanchez Turrion,Neville V. Jamieson,T. Scholz,Michele Colledan,Fred Fändrich,Thomas Becker,Gunnar Söderdahl,Olivier Chazouillères,Heikki Mäkisalo,Georges-Philippe Pageaux,Rudolf Steininger,Thomas Soliman,Koert P. de Jong,Jacques Pirenne,Raimund Margreiter,Johann Pratschke,Antonio Daniele Pinna,Johann Hauss,Stefan Schreiber,Simone I. Strasser,Jürgen Klempnauer,Roberto Troisi,Sherrie Bhoori,Jan Lerut,Itxarone Bilbao,Christian Klein,Alfred Königsrainer,Darius F. Mirza,Gerd Otto,Vincenzo Mazzaferro,Peter Neuhaus,Hans J. Schlitt +68 more
TL;DR: This trial provides the first high-level evidence base for selecting immunosuppression in LTx recipients with HCC and reveals that low-risk, rather than high- risk, patients benefited most from sirolimus; furthermore, younger recipients (age ⩽60) also benefited, as well siro Limus monotherapy patients.
Journal ArticleDOI
Liver Transplantation for Neuroendocrine Tumors in Europe-Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study.
Yves Patrice Le Treut,Emilie Gregoire,Jürgen Klempnauer,Jacques Belghiti,Elisabeth Jouve,Jan Lerut,Denis Castaing,Olivier Soubrane,Olivier Boillot,Georges Mantion,Kia Homayounfar,Manuel Bustamante,Daniel Azoulay,Philippe Wolf,Marek Krawczyk,Andreas Pascher,Bertrand Suc,Laurence Chiche,Jorge Ortiz De Urbina,Vladimir Mejzlik,Manuel Pascual,J. Peter A. Lodge,Salvatore Gruttadauria,François Paye,François-René Pruvot,Stefan Thorban,Aksel Foss,René Adam +27 more
TL;DR: LT is an effective treatment of unresectable LM from neuroendocrine tumors (NET) over a 27-year period and patient selection based on the aforementioned predictors can achieve a 5-year OS between 60% and 80%.
Journal ArticleDOI
Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure–a multicenter European study
Marie-Pierre Chenard-Neu,Karim Boudjema,Jacques Bernuau,Claude Degott,Jacques Belghiti,Daniel Cherqui,V Costes,Jacques Domergue,François Durand,Erhard J,B. de Hemptinne,G Gubernatis,Antoine Hadengue,J Kemnitz,M McCarthy,H Maschek,Gilles Mentha,Karl J. Oldhafer,Bernard Portmann,Marleen Praet,Jan Ringers,Xavier Rogiers,L Rubbia,S.W. Schalm,Fibo W. J. Ten Kate,Onno T. Terpstra,B. van Hoek,Roger Williams,Elie-Serge Zafrani,Jacques Cinqualbre,Philippe Wolf,Daniel Jaeck,Bellocq Jp +32 more
TL;DR: Auxiliary liver transplantation is a special procedure which could be proposed to patients with fulminant hepatic failure and has for aim that complete regeneration of the native liver left in place will allow the graft recipient to resume normal liver function after allograft withdrawal.
Journal ArticleDOI
Small hepatocellular carcinoma in Child A cirrhotic patients: Hepatic resection versus transplantation
Jean-Marc Bigourdan,Daniel Jaeck,Nicolas Meyer,Carole Meyer,Elie Oussoultzoglou,Philippe Bachellier,Jean-Christophe Weber,Maxime Audet,Michel Doffoel,Philippe Wolf +9 more
TL;DR: It is concluded that in patients with Child A cirrhosis and small HCC, liver transplantation resulted in better overall and disease‐free survival than HR.
Journal ArticleDOI
Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study
Daniel Jaeck,Hiroshi Nakano,Philippe Bachellier,Keiichiro Inoue,Jean-Christophe Weber,Elie Oussoultzoglou,Philippe Wolf,Marie-Pierre Chenard-Neu +7 more
TL;DR: HP-LN involvement was the most significant prognostic indicator in patients with colorectal liver metastases and positive LNs of area 1 should no longer be considered an absolute contraindication to liver resection, but in case of area 2 lymph node involvement, Liver resection does not seem justified.